Literature DB >> 6778867

Purification and preliminary physicochemical characterization of human platelet membrane glycoprotein V.

M C Berndt, D R Phillips.   

Abstract

Treatment of human platelets with alpha-thrombin leads to the selective hydrolysis of only one membrane protein, glycoprotein V. To determine whether glycoprotein V was directly cleaved by alpha-thrombin and to permit further characterization of this glycoprotein as the potential functional thrombin receptor, glycoprotein V was purified to > 98% homogeneity. Washed platelets were prepared from concentrates within 18 h of venipuncture, since clinically expired platelets (> 72 h from venipuncture) were shown to contain little or no detectable glycoprotein V. Glycoprotein V was eluted from the platelet membrane by equilibrating the platelets (4 X 10(9)/ml) at 37 degrees C for 24 h in 0.01 M 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (Hepes), pH 7.6 (1 mM in EDTA, 0.3 M in NaCl). Purification was achieved by initially performing ammonium sulfate fractionation, followed by chromatography on Sephacryl S-200, hydroxylapatite, and DEAE- and CM-cellulose, and yielded 0.5 to 1.0 mg of purified glycoprotein per 100 units of platelet concentrate (approximately 6 X 10(12) platelets). Purified glycoprotein V (Mr = 82,000) was a thrombin substrate, and on hydrolysis yielded a major fragment, GPVf1 (Mr = 69,500), identical in molecular weight with that observed previously in the supernatant of thrombin-treated, periodate-labeled platelets. Glycoprotein V existed as at least eight distinct isoelectric forms with pI values ranging from 5.85 +/- 0.05 to 6.55 +/- 0.05. The purified glycoprotein contained approximately 48% carbohydrate by weight, consisting of neutral hexose, hexosamine, and sialic acid in a molar ratio of approximately 8:2:1. Rabbit antiglycoprotein V antibody gave a single precipitin line against purified glycoprotein V, which showed a line of complete identity with Triton-solubilized washed platelets. The availability of purified glycoprotein V and antiglycoprotein V antibody will be useful in delineating the role of this glycoprotein in thrombin activation of platelets.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6778867

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Increased thrombin responsiveness in platelets from mice lacking glycoprotein V.

Authors:  V Ramakrishnan; P S Reeves; F DeGuzman; U Deshpande; K Ministri-Madrid; R B DuBridge; D R Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

2.  A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion.

Authors:  M Moroi; S M Jung; M Okuma; K Shinmyozu
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

3.  Developmentally regulated expression of a 78 kDa erythroblast membrane glycoprotein immunologically related to the platelet thrombospondin receptor.

Authors:  N Kieffer; A Bettaieb; C Legrand; L Coulombel; W Vainchenker; L Edelman; J Breton-Gorius
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

4.  Linkage of a membrane skeleton to integral membrane glycoproteins in human platelets. Identification of one of the glycoproteins as glycoprotein Ib.

Authors:  J E Fox
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

5.  Hydrolysis of human platelet membrane glycoproteins with a Serratia marcescens metalloprotease: effect on response to thrombin and von Willebrand factor.

Authors:  H A Cooper; W P Bennett; G C White; R H Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

6.  Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium. Studies utilizing patients with quantitative and qualitative platelet defects.

Authors:  H J Weiss; V T Turitto; H R Baumgartner
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

7.  Isolation of a platelet membrane protein which binds the platelet-activating factor 1-0-hexadecyl-2-acetyl-SN-glycero-3-phosphorylcholine.

Authors:  F H Valone
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

8.  Human platelet glycoprotein V: characterization of the polypeptide and the related Ib-V-IX receptor system of adhesive, leucine-rich glycoproteins.

Authors:  M J Hickey; F S Hagen; M Yagi; G J Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

9.  Mechanisms of thrombin-induced modifications of human platelet cytoskeleton.

Authors:  F Sinigaglia; C L Balduini; A Bisio; C Balduini
Journal:  Biochem J       Date:  1985-11-15       Impact factor: 3.857

Review 10.  The organizing principle of the platelet glycoprotein Ib-IX-V complex.

Authors:  R Li; J Emsley
Journal:  J Thromb Haemost       Date:  2013-04       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.